Penny Breeze

All publications

Journal articles

• Mueller J, Jones RA, Richards R, Woolston J, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ, Boothby C , Bostock J et al (2023) Feasibility and acceptability of an acceptance-based guided self-help programme for weight loss maintenance. Appetite, 189, 106907-106907.
• Scragg J, Morris E, Wane S, Noreik M, Jerome D, Yu L-M, Galal U, Dyson P, Tan GD, Fox R , Breeze P et al (2023) Dietary approaches to the management of type 2 Diabetes (DIAMOND) in primary care: a protocol for a cluster randomised trial. Contemporary Clinical Trials, 129.
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) Guidance on the use of complex systems models for economic evaluations of public health interventions. Health Economics.
• Ahern AL, Breeze P, Fusco F, Sharp SJ, Islam N, Wheeler GM, Hill AJ, Hughes CA, Duschinsky R, Thomas C , Bates S et al (2022) Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. The Lancet Public Health, 7(10), e866-e875.
• Bates SE, Thomas C, Islam N, Ahern AL, Breeze P, Griffin S & Brennan A (2022) Using health economic modelling to inform the design and development of an intervention : estimating the justifiable cost of weight loss maintenance in the UK. BMC Public Health, 22(1). View this article in WRRO
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al (2022) Development of a Web-Based, Guided Self-help, Acceptance and Commitment Therapy-Based Intervention for Weight Loss Maintenance: Evidence-, Theory-, and Person-Based Approach.. JMIR Form Res, 6(1), e31801.
• Breeze P, Thomas C, Thokala P, LaFortune L, Brayne C & Brennan A (2020) The impact of including costs and outcomes of dementia in a health economic model to evaluate lifestyle interventions to prevent diabetes and cardiovascular disease. Medical Decision Making.
• Thomas C, Brennan A, Squires H, Brenner G, Bagguley D, Woods H, Gillett M, Leaviss J, Clowes M, Heathcote L , Cooper K et al (2020) What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation. BMJ Open, 10(9). View this article in WRRO
• Bates S, Bayley T, Norman P, Breeze P & Brennan A (2019) A systematic review of methods to predict weight trajectories in health economic models of behavioral weight management programs : the potential role of psychosocial factors. Medical Decision Making. View this article in WRRO
• Breeze P, Womack R, Pryce R, Brennan A & Goyder E (2018) The impact of a local sugar sweetened beverage health promotion and price increase on sales in public leisure centre facilities. PLoS ONE, 13(5). View this article in WRRO
• Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V , Lamotte M et al (2018) Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge. Value in Health. View this article in WRRO
• Thomas C, Sadler S, Breeze P, Squires H, Gillett M & Brennan A (2017) Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open, 7. View this article in WRRO
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2017) Cost‐effectiveness of population‐based, community, workplace and individual policies for diabetes prevention in the UK. Diabetic Medicine, 34(8), 1136-1144. View this article in WRRO
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, Brunner E, Tabak A, Preston L & Chilcott J (2017) The impact of Type 2 diabetes prevention programmes based on risk‐identification and lifestyle intervention intensity strategies: a cost‐effectiveness analysis. Diabetic Medicine, 34(5), 632-640. View this article in WRRO
• Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study.. J Public Health (Oxf), 38(4), 679-687. View this article in WRRO
• Thomas C, Breeze P, Strong M, Brennan A, Norman P, Cameron D & Epton T (2016) The cost-effectiveness of an updated theory-based online health behavior intervention for new university students: U@Uni2. Journal of Public Health & Epidemiology, 8(10), 191-203. View this article in WRRO
• (2016) Retracted:Impact of Type 2 diabetes prevention programmes based on risk identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. Diabetic Medicine, 33(8), 1155-1163.
• Simpson EL, Davis S, Thokala P, Breeze PR, Bryden P & Wong R (2015) Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. PharmacoEconomics, 33(11), 1187-1194. View this article in WRRO
• Breeze P & Brennan A (2015) Valuing Trial Designs from a Pharmaceutical Perspective Using Value-Based Pricing. Health Economics (United Kingdom), 24(11), 1468-1482. View this article in WRRO
• Strong M, Oakley JE, Brennan A & Breeze P (2015) Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample. Medical Decision Making, 35(5), 570-583. View this article in WRRO
• Watson P, Brennan A, Birch H, Fang H & Petri M (2015) An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort. Rheumatology, 54(4), 623-632.
• Watson P, Preston L, Squires H, Chilcott J & Brennan A (2014) Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods.. Appl Health Econ Health Policy, 12(3), 239-253.
• Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A & Zlateva G (2010) Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
• Thomas C, Breeze P, Cummins S, Cornelsen L, Yau A & Brennan A () The health, cost and equity impacts of restrictions on the advertisement of high fat, salt and sugar products across the Transport for London network: A health economic modelling study. International Journal of Behavioral Nutrition and Physical Activity.
• Breeze P, Gray LA, Thomas C, Bates SE & Brennan A () Estimating the impact of changes in weight and BMI on EQ-5D-3L: a longitudinal analysis of a behavioural group-based weight loss intervention. Quality of Life Research.
• Gray L, Breeze P & Williams E () BMI Trajectories, Morbidity and Mortality in England: A 2-step Approach to Estimating Consequences of Changes in BMI. Obesity.
• Marr C, Breeze P & Caton SJ () Examination of dietary intake of UK preschool children by varying carers: Evidence from the 2008-2016 UK National Diet and Nutrition Survey. British Journal of Nutrition, 1-35.
• Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S & Gray LJ () The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study. Health Technology Assessment, 19(33), 1-80.
• Kearney C, Reale S, Breeze P & Caton S () Grandparental dietary provision, feeding practices and feedings styles when caring for preschool aged grandchildren: a systematic mixed methods review. Obesity Reviews.
• Bates S, Norman P, Breeze P, Brennan A & Ahern AL () Mechanisms of Action in a Behavioral Weight-Management Program: Latent Growth Curve Analysis. Annals of Behavioral Medicine. View this article in WRRO
• Marr C, Breeze P & Caton S () A comparison between parent and grandparent dietary provision, feeding styles and feeding practices when caring for preschool-aged children. Appetite.

Conference proceedings papers

• Bates S, Breeze P, Norman P & Brennan A (2021) Exploring the cost effectiveness of behavioural weight-management interventions based on the expected impact on mechanisms of action : a pre-trial health economic modelling study. The Lancet, Vol. 398(Supplement 2) (pp 23-23). Virtual conference, 26 November 2021 - 26 November 2021. View this article in WRRO
• Breeze P, Sworn K, Abraham S, McGrane E, Cantrell A & Brennan A (2021) Estimating the health impact of individual's dietary change across multiple physiological outcomes: a conceptual and simulation model. The Lancet, Vol. 398 (pp S27-S27)
• Thomas C, Watson P, Greaves C, Squires H, Chilcott J & Brennan A (2014) Layering Interventions for Type-2 Diabetes Prevention Using The Sphr Diabetes Model. Value in Health, Vol. 17(7) (pp A347-A347)
• Thomas C, Watson P, Squires H, Chilcott J & Brennan A (2014) Validation of the SPHR Diabetes Prevention Model. Value in Health, Vol. 17(7) (pp A556-A556)
• Watson P & Brennan A (2013) The expected value of sample information from the pharmaceutical perspective under conditions of value based pricing. Value in Health, Vol. 16(3) (pp A29-A29)
• Watson P & Brennan A (2012) Validation of an individual patient level simulation of the natural history of systemic Lupus erythematosus against an alternative longitudinal cohort. 2012 Operational Research Society Simulation Workshop, SW 2012 (pp 19-24)
• Watson P, Brennan A, Birch H, Fang H & Petri M (2011) The Natural History and Predictive Factors of Long Term Outcomes in Systemic Lupus Erythematosus.. ARTHRITIS AND RHEUMATISM, Vol. 63(10) (pp S951-S951)

Preprints

• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al () Development of a Web-Based, Guided Self-help, Acceptance and Commitment Therapy–Based Intervention for Weight Loss Maintenance: Evidence-, Theory-, and Person-Based Approach (Preprint), JMIR Publications Inc..